CWM
TGTX icon

CIBC World Markets’s TG Therapeutics TGTX Stock Holding History

CIBC World Markets’s Portfolio TGTX Stock Details TGTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$286K Buy
+9,609
New +$314K ﹤0.01% 974
2025
Q2 		$644K Sell
17,896
-13,084
-42% -$487K ﹤0.01% 770
2025
Q1 		$1.22M Buy
30,980
+17,915
+137% +$603K 0.01% 632
2024
Q4 		$393K Buy
+13,065
New +$375K ﹤0.01% 821

Other funds holding TGTX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $9.98B AUM 145.42% 1-Year Est. Return

CIBC World Markets's TGTX Position: Q4 2025 in Review

CIBC World Markets opened a new position in TG Therapeutics (TGTX) in Q4 2025: 9,609 shares worth $286K. The stake represents ﹤0.01% of the portfolio and ranks #974 among its holdings. This is a return to the name: CIBC World Markets previously reported a position in TGTX as recently as Q2 2025.

CIBC World Markets first reported a position in TGTX in Q4 2024 and has held it in 4 quarters since. The position peaked at $1.22M in Q1 2025. 351 funds tracked by Wall St. Rank hold TGTX as of Q4 2025.

  • CIBC World Markets held 9,609 shares of TG Therapeutics worth $286K as of Q4 2025.
  • TG Therapeutics was a new CIBC World Markets position in Q4 2025.
  • TG Therapeutics made up ﹤0.01% of CIBC World Markets's portfolio in Q4 2025, its #974 holding.
  • CIBC World Markets first reported a position in TG Therapeutics in Q4 2024 and has held it in 4 quarters since.
  • CIBC World Markets's TG Therapeutics position peaked at $1.22M in Q1 2025.
  • 351 funds tracked by Wall St. Rank held TG Therapeutics as of Q4 2025.

Based on CIBC World Markets's 13F filing for Q4 2025, filed 12 Feb 2026.